Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06669533 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Use Misoprostol to Optimize Prevention of Cervical Cancer

Name: Use Misoprostol to Optimize Prevention of Cervical Cancer — clinical trial record (NCT06669533)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: MISOPCx

StatusRecruiting

PhaseNot applicable

SponsorUniversity of Alabama at Birmingham

Started2025-02-25

View on ClinicalTrials.gov ↗

This is a double-blind randomized controlled trial of 420 non-pregnant women undergoing cancer screening by visual inspection with acetic acid (VIA) who have Type 3 transformation zone (TZ) and randomized to receive either Misoprostol or placebo.

Amendment history 2 changes detected by DataLookout

2026-09-01

Primary completion pushed: 2026-11-04 → 2027-11-04

2026-09-01

Completion pushed: 2027-11-04 → 2028-11-11

Trial Details

NCT Number	NCT06669533
Lead Sponsor	University of Alabama at Birmingham Collaborators: Cameroon Baptist Convention Health, National Cancer Institute (NCI)
Conditions	Cervical Cancers
Enrollment	420 participants
Start Date	2025-02-25
Primary Completion	2027-11-04 (estimated)
Study Completion	2028-11-11 (estimated)
Updated on ClinicalTrials.gov	2026-08-31